(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of -5.63% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Masimo's revenue in 2025 is $2,094,400,000.On average, 5 Wall Street analysts forecast MASI's revenue for 2025 to be $81,764,573,360, with the lowest MASI revenue forecast at $81,678,471,088, and the highest MASI revenue forecast at $81,970,873,541. On average, 5 Wall Street analysts forecast MASI's revenue for 2026 to be $88,076,366,229, with the lowest MASI revenue forecast at $87,682,971,638, and the highest MASI revenue forecast at $88,705,301,246.
In 2027, MASI is forecast to generate $95,113,878,248 in revenue, with the lowest revenue forecast at $94,701,709,477 and the highest revenue forecast at $95,939,834,253.